Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Abatacept
Orencia
Not routinely available
SMC (1287/17)
13/11/2017
Indication
Alone or in combination with methotrexate for the treatment of active psoriatic arthritis in adult patients when the response to previous disease-modifying anti-rheumatic drug (DMARD) therapy including methotrexate has been inadequate, and for whom additional systemic therapy for psoriatic skin lesi...
Therapeutic Area
Musculoskeletal and joint diseases
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
125mg solution for injection (pre-filled syringe); 125mg solution for injection in pre-filled pen; 250mg powder for concentrate for solution for infusion
Comments
None
Link to Advice
Advice Published
13/11/2017
SMC Submission Type
Non submission
SMC Status
Not recommended